Improvement of Mitochondrial Toxicity in Patients Receiving a Nucleoside Reverse‐Transcriptase Inhibitor–Sparing Strategy: Results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA)-Reference-Cited by-同舟云学术

Improvement of Mitochondrial Toxicity in Patients Receiving a Nucleoside Reverse‐Transcriptase Inhibitor–Sparing Strategy: Results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA)

Published:2009-09-15 Issue:6 Volume:49 Page:892-900
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:CLIN INFECT DIS

Author:

Negredo Eugenia,Miró Òscar,Rodríguez‐Santiago Benjamí,Garrabou Glòria,Estany Carla,Masabeu Àngels,Force Lluís,Barrufet Pilar,Cucurull Josep,Domingo Pere,Alonso‐Villaverde Carlos,Bonjoch Anna,Morén Constanza,Pérez‐Álvarez Núria,Clotet Bonaventura,

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/49/6/892/956647/49-6-892.pdf

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of genetic variations in drug transporters, metabolizing enzyme and regulatory genes on the development of HIV‐associated lipodystrophy;The Journal of Gene Medicine;2023-04-04

2. The Emerging Role of the Innate Immune Response in Idiosyncratic Drug Reactions;Pharmacological Reviews;2021-05-20

3. Emergence of dual antiretroviral therapy as a viable regimen option for the treatment of patients with HIV infection;Drugs of Today;2020

4. Salvage Antiretroviral Therapy: Time for “DeNUKElearization”?;The Journal of Infectious Diseases;2019-05-28

5. Switching to dual antiretroviral regimens is associated with improvement or no changes in activation and inflammation markers in virologically suppressed HIV‐1‐infected patients: the TRILOBITHE pilot study;HIV Medicine;2019-05-26